Autopsy report · NCT02951117

A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“No participants enrolled”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: AbbVie
Sponsor type: Industry
Conditions: Multiple Myeloma
Interventions: Venetoclax; ABBV-838; Dexamethasone
Participants: 0
Sites: 3
Countries: Australia

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.